Concepedia

Author

R M Sharkey

Center for Molecular Medicine and Immunology

Also Known As

R M Sharkey, R. M. Sharkey, R. Sharkey, Robert M. Sharkey, RobertM. Sharkey

26

Publications

1K

Citations

19

H-Index

51

Concepts

All Affiliations

Center for Molecular Medicine and ImmunologyImmunomedics (United States)Immunomedics (Germany)
RM

About

R M Sharkey is an author at Center for Molecular Medicine and Immunology specializing in medicine, oncology, and cancer research.

Top Concepts

#ConceptH-IndexPublicationsCitations

1

Medicine

15

15

784

2

Health Sciences

6

6

212

3

Engineering

3

3

115

4

Allergy

1

1

21

5

Biochemistry

1

1

160

R M Sharkey

×

20

Publications

995

Citations

19

H-Index

YearCitations

Reduction of the renal uptake of radiolabeled monoclonal antibody fragments by cationic amino acids and their derivatives.

Th. Behr, R M Sharkey, Malik E. Juweid,

PubMed

1995

160

Biodistribution and radiation dose estimates for yttrium- and iodine-labeled monoclonal antibody IgG and fragments in nude mice bearing human colonic tumor xenografts.

R M Sharkey, Cecilia Motta‐Hennessy, David Pawlyk,

PubMed

1990

105

Radioimmunotherapy of human colonic cancer xenografts with 90Y labeled monoclonal antibodies to carcinoembryonic antigen.

R M Sharkey, Florence Kaltovich, Lisa B. Shih,

PubMed

1988

78

Advances in cancer therapy with radiolabeled monoclonal antibodies.

David M. Goldenberg, R M Sharkey

PubMed

2006

73

Tumor, red marrow, and organ dosimetry for 131I-labeled anti-carcinoembryonic antigen monoclonal antibody.

J A Siegel, David Pawlyk, Robert Lee,

PubMed

1990

61

Murine monoclonal antibodies against carcinoembryonic antigen: immunological, pharmacokinetic, and targeting properties in humans.

R M Sharkey, D M Goldenberg, H Goldenberg,

PubMed

1990

59

Improved therapy of non-Hodgkin's lymphoma xenografts using radionuclides pretargeted with a new anti-CD20 bispecific antibody

R M Sharkey, Habibe Karacay, CH Chang,

Leukemia

2005

51

Pretargeting for Cancer Radioimmunotherapy with Bispecific Antibodies:  Role of the Bispecific Antibody's Valency for the Tumor Target Antigen

Habibe Karacay, R M Sharkey, William J. McBride,

Bioconjugate Chemistry

2002

50

Factors influencing the pharmacokinetics, dosimetry, and diagnostic accuracy of radioimmunodetection and radioimmunotherapy of carcinoembryonic antigen-expressing tumors.

Th. Behr, R M Sharkey, M I Juweid,

PubMed

1996

48

Neutron-capture therapy of human cancer: in vivo results on tumor localization of boron-10-labeled antibodies to carcinoembryonic antigen in the GW-39 tumor model system.

D M Goldenberg, R M Sharkey, F. James Primus,

Proceedings of the National Academy of Sciences

1984

42

Page 1